000			01519 a2200373 4500
005			20250517211036.0
264		0	_c20190909
008			201909s 0 0 eng d
022			_a1873-2402
024	7		_a10.1016/j.biopsych.2018.03.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aBarnes, Samuel A
245	0	0	_aMetabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy. _h[electronic resource]
260			_bBiological psychiatry _c06 2018
300			_a955-962 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aDepressive Disorder, Major _xdrug therapy
650	0	4	_aDrug Discovery
650	0	4	_aExcitatory Amino Acid Antagonists _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReceptor, Metabotropic Glutamate 5 _xagonists
650	0	4	_aSmoking _xdrug therapy
650	0	4	_aSynaptic Transmission _xdrug effects
650	0	4	_aTobacco Use Disorder _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aSheffler, Douglas J
700	1		_aSemenova, Svetlana
700	1		_aCosford, Nicholas D P
700	1		_aBespalov, Anton
773	0		_tBiological psychiatry _gvol. 83 _gno. 11 _gp. 955-962
856	4	0	_uhttps://doi.org/10.1016/j.biopsych.2018.03.001 _zAvailable from publisher's website
999			_c28260811 _d28260811